Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Al Mayadeen's correspondent in South Lebanon: Israeli drone drops sonic grenade in town of Ramiyah.
Al Mayadeen's correspondent in South Lebanon: Israeli drone strike targets vehicle in town of Beit Lif.
The Government Media Office in Gaza: The occupation’s latest crime is further evidence of its ongoing implementation of genocide through starvation.
Gaza Government Media Office: This is a methodical use of aid as a tool of war to blackmail hungry civilians.
Gaza Government media office: Massacre committed by occupation today is a blatant war crime under international law.
Al Mayadeen's correspondent: Waves of injured and martyrs continue to arrive at Nasser Medical Complex following the horrific massacre near the aid distribution centers in Rafah.
Al Mayadeen's correspondent in Gaza: 30 martyrs and 120 wounded by Israeli fire while heading to a 'US aid distribution site' west of Rafah.
Araghchi to Grossi: These parties will bear responsibility for the consequences of their actions
Araghchi to Grossi: Iran will respond to any unlawful action by European countries or parties attempting to turn the Agency into a tool for achieving their objectives
Araghchi to Grossi: We urge the Agency to warn against the consequences of any political move against Iran

FDA approves new drug to treat Alzheimer's

  • By Al Mayadeen English
  • Source: Agencies
  • 7 Jan 2023 00:04
2 Min Read

The FDA approved Leqembi, also known as lecanemab, just days after the agency was heavily criticized in a congressional report for its approval of another Alzheimer's medicine, Aduhelm.

  • x
  • Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US. (REUTERS)
    Signage is seen outside of the Food and Drug Administration (FDA) headquarters in the US. (Reuters)

The US Food and Medicine Administration authorized a long-awaited new drug aimed to reduce cognitive deterioration in Alzheimer's patients on Friday.

The FDA approved Leqembi, also known as lecanemab, just days after the agency was heavily criticized in a congressional report for its approval of another Alzheimer's medicine, Aduhelm.

In September, preliminary findings from a Leqembi trial revealed that it delayed cognitive loss in Alzheimer's patients by 27% over an 18-month period.

Leqembi and Aduhelm "represent an important advancement in the ongoing fight to effectively treat Alzheimer's disease," the FDA said in a statement as quoted by AFP.

Related News

New blood biomarker can predict Alzheimer's disease

The FDA authorized both treatments using an accelerated process, which allows the US regulatory agency to expedite the approval of drugs for serious illnesses with unmet medical needs.

Sources reported on December 30 that the 2021 FDA's approval of an Alzheimer's drug called Aduhelm was "rife with irregularities" as an 18-month congressional investigation found an "atypical collaboration" between FDA regulators and Aduhelm manufacturer, Biogen. 

According to the probe, investigators found that the company intended to "make history" when it set an "unjustifiably high" initial yearly price of $56,000 for the drug.

This comes against the backdrop of criticism as the FDA is expected to decide on approving another drug for treating the disease in January.

The report also found that there was an unusually high amount of phone exchanges between company officials and FDA delegates.

Read next: Scientists develop new blood test for Alzheimer’s disease

  • FDA
  • Alzheimer
  • Leqembi
  • Alzheimer's medicine

Most Read

President Donald Trump and Israeli Prime Minister Benjamin Netanyahu arrive to a news conference in the East Room of the White House, Tuesday, Feb. 4, 2025, in Washington (AP)

Rift widens: Trump, Netanyahu clash in heated phone call over Iran

  • Politics
  • 26 May 2025
US judges quietly consider private security amid Trump tensions

US judges quietly consider private security amid Trump pressures

  • US & Canada
  • 25 May 2025
An Israeli army vehicle moves in the Gaza Strip as seen from southern occupied Palestine, Thursday, May 29, 2025 (AP)

Hamas rejects Witkoff ceasefire plan, says alters terms

  • Politics
  • 29 May 2025
Spokesperson for the Yemeni Armed Forces, Brigadier General Yahya Saree, announces a new operation against Ben Gurion Airport on May 29, 2025 (Yemeni Military Media)

Yemen announces successful hypersonic missile strike on Ben Gurion

  • Politics
  • 30 May 2025

Coverage

All
War on Gaza

Read Next

All
MIT bans class president who gave pro-Palestine speech
US & Canada

MIT bans class president over pro-Palestine speech

Arab ministers condemn Israel 'ban' on planned West Bank visit
Politics

Arab ministers condemn Israeli ban on planned West Bank visit

Major General Hu Gangfeng, Vice President, National Defense University, People's Liberation Army, China, leaves after a panel discussion during the 22nd Shangri-La Dialogue summit in Singapore, Saturday, May 31, 2025. (AP Photo/Anupam Nath)
Politics

China blasts Hegseth, calls US top 'troublemaker' in Asia-Pacific

US activists demand shutdown of Musk's 'dirty' supercomputer: Reports
Technology

US activists demand shutdown of Musk's 'dirty' supercomputer: NBC News

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS